Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
5
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
5
×
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
5
×
wisconsin blog main
wisconsin top stories
clinical trials
eli lilly
bristol-myers squibb
celgene
deals
fda
investing
johnson & johnson
medicare
merck
nivolumab
What
companies
5
×
bio
roundup
drug
ipo
latest
life
nash
new
news
price
science
week
alzheimer’s
approval
approved
arena’s
biogen’s
biopharmaceutical
biotechs
bounty
cig
club
comeback
continued
convo
corner
crop
deals
delivered
different
digital
disease
earlier
epidemic
exceeded
expressing
fail
failures
fatty
Language
Current search:
companies
×
" texas top stories "
×
" cancer immunotherapy "
×
" san diego blog main "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M